2-methoxyestradiol

DRUG3 trials

Sponsors

National Cancer Institute (NCI), CASI Pharmaceuticals, Inc.

Conditions

Plateau Phase Multiple MyelomaRefractory Multiple MyelomaRelapsed Multiple MyelomaStage III Multiple MyelomaUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

CompletedNCT00030095

National Cancer Institute (NCI)Unspecified Adult Solid Tumor, Protocol Specific

Start: 2001-09-30Updated: 2015-04-30

2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors

CompletedNCT00028821

National Cancer Institute (NCI)Refractory Multiple Myeloma, Stage III Multiple Myeloma, Unspecified Adult Solid Tumor, Protocol Specific

Start: 2002-01-31Updated: 2013-01-16

Phase 2

A Phase 2 Study With Panzem in Patients With Relapsed or Plateau Phase Multiple Myeloma

CompletedNCT00592579

CASI Pharmaceuticals, Inc.Plateau Phase Multiple Myeloma, Relapsed Multiple Myeloma

Start: 2001-03-31End: 2008-09-30Updated: 2009-02-26